At close: December 20 at 4:00:00 PM EST
Pre-Market: 8:19:21 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
-539.0000
-537.0000
-1,132.0000
Investing Cash Flow
--
--
-3.0000
Financing Cash Flow
541.0000
505.0000
648.0000
End Cash Position
23.0000
4.0000
36.0000
Capital Expenditure
--
--
-3.0000
Issuance of Capital Stock
341.0000
256.0000
--
Issuance of Debt
200.0000
249.0000
648.0000
Free Cash Flow
-539.0000
-537.0000
-1,135.0000
12/31/2022 - 10/29/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGTX Cognition Therapeutics, Inc.
0.6301
-0.62%
BPTH Bio-Path Holdings, Inc.
1.2600
-15.44%
PRTG Portage Biotech Inc.
5.96
+1.88%
TNXP Tonix Pharmaceuticals Holding Corp.
0.6116
+7.30%
PBM Psyence Biomedical Ltd.
3.1800
+29.27%
ELAB Elevai Labs Inc.
2.5600
+8.94%
CERO CERo Therapeutics Holdings, Inc.
0.0561
+3.89%
HUMA Humacyte, Inc.
4.6400
+34.10%
APTO Aptose Biosciences Inc.
0.2790
+63.92%
CADL Candel Therapeutics, Inc.
8.75
-12.15%